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Epidemiology of human rabies in Turkey:
1992-2007
Aim: Rabies continues to be a public health problem in Turkey; however, the number of reported
cases has decreased in recent years and 1-2 cases of human rabies are reported annually to the
Ministry of Health (MoH). Epidemiological and demographic features, clinical findings, and
prophylaxis of human rabies reported to the MoH between 1992 and 2007 were evaluated.
Materials and Methods: Rabies has been reported in Turkey since 1930. Data on human rabies have
been available from the MoH since 1992. In this study, data on human rabies were analyzed
retrospectively. The provinces, rabies risk exposure date, age, gender, type of animal, and prophylaxis
program of the patients were recorded. Diagnoses of the cases were made based on clinical or
laboratory findings.
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Results: Thirty-nine human rabies cases (31 male, 8 female) were reported to the MoH between
1992 and 2007. Diagnosis of 17 rabies cases was confirmed by pathological findings or detection of
the viral genome by PCR. The remaining 22 cases were confirmed according to epidemiological data
and clinical findings. Mean age of the patients was 28.6 ± 19.3 years (range: 5-69 years). The 3
provinces that most frequently reported human rabies were İstanbul (11 cases), Şanlıurfa (5 cases),
and İzmir (4 cases). Among the 39 cases, 29 were attributable to dog bites, 3 were related to wild
animal exposure, and in 2 cases there was a history of contact with foxes. Twenty-two of the 39
patients did not receive post-exposure prophylaxis. In the remaining 17 patients the first dose of
vaccine was administered 15 days after exposure to 5 patients, 12 patients were vaccinated on the day
of rabies risk exposure, but 7 of these 12 patients did not receive any rabies immunoglobulin. In 5
patients the immunoglobulin was administered 3 days after exposure. Vaccination and
immunoglobulin administration were performed at the appropriate time in 2 patients.
Conclusions: According to these results, dogs were most responsible for the development of rabies.
Among the 39 patients, 37 either did not receive post-exposure prophylaxis or were inappropriately
administered vaccine and immunoglobulin. Human rabies developed in 2 patients despite the fact
that vaccination and immunoglobulin administration were performed at the appropriate time and
dosage.
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Türkiye’de İnsan Kuduzu Olgularının Epidemiyolojisi:
1992-2007
Amaç: Kuduz yılda bir-iki vaka ile de olsa ülkemizde halen sorun olmaya devam eden bir halk sağlığı
problemidir. Bu yazıda 1992-2007 yılları arasında kuduz tanısı ile Sağlık Bakanlığına bildirilen
olguların epidemiyolojik ve demografik özellikleri, klinik özellikleri ile uygulanan profilaksi
şemalarının incelenmesi amaçlandı.
Yöntem ve Gereç: Kuduz Türkiye’de 1930 tarihinden itibaren bildirimi zorunlu bir hastalıktır. Kuduz
olgularının detaylı bilgileri 1992 yılından itibaren Sağlık Bakanlığı kayıtlarında mevcut olup; bu
veriler retrospektif olarak analiz edildi. Olguyu bildiren il, kuduz riskli temas tarihi, olguların yaşı,
cinsiyeti, kuduz riskli temasa neden olan hayvan ve temas sonrası profilaksi durumları kaydedildi.
Kuduz olgularına tanısı laboratuar incelemeleri ile ya da klinik olarak konulmuştu.
Bulgular: 1992-2007 yılları arasında Sağlık Bakanlığı’na 39 kuduz olgusu (31 erkek, 8 kadın)
bildirildiği saptandı. Otuz dokuz olgudan 17’sinin tanısının laboratuar olarak doğrulandığı, kalan
22 vakaya epidemiyolojik öykü ve klinik bulgulara göre tanı konduğu belirlendi. Olguların yaş
ortalamaları 28,6 ± 19,3 (min. 5, max. 69) idi. Kuduz riskli temasın gerçekleştiği il olarak İstanbul ilk
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sırada gelirken (11 olgu) bunu sırası ile Şanlıurfa (5 olgu) ve İzmir’in (4 olgu) izlediği saptandı. Kuduz
riskli temasa en sık yol açan hayvanın köpek olduğu (29 olgu), ikinci ve üçüncü sırada vahşi hayvan
(3 olgu) ve tilkinin (2 olgu) yer aldığı belirlendi. Kuduz tanısı konan 39 olgudan 22’sinin temas sonrası
profilaksi almadığı belirlendi. Kalan 17 olgudan 5’ine ilk doz aşının 15 gün veya daha geç yapıldığı,
zamanında aşı programına başlanan 12 olgunun 7’sinde anti-serum uygulanmadığı saptandı. Antiserum uygulaması yapılan 5 olgunun ikisinde anti-serum ve aşı uygulamasının zamanında başlandığı
saptandı.
Sonuç: Ülkemizde görülen kuduz olgularında kuduz riskli temasa en sık yol açan hayvanın köpek
olduğu belirlendi. Kuduz gelişen 39 olgunun 37’sinde profilaksi programının geç veya eksik
uygulandığı iki olguda ise zamanında ve uygun dozda profilaksi yapılmasına rağmen kuduz geliştiği
belirlendi.
Anahtar sözcükler: Kuduz, Türkiye, profilaksi

Introduction
Rabies is a lethal form of encephalitis caused by
the rabies virus (1). Approximately 55,000 people die
annually due to rabies, according to World Health
Organization (WHO) data (2). Most rabies cases were
reported from Asian and African countries, and 30%50% of them were in patients under the age of 15 years
(2). The incidence of rabies is very low in Europe and
the virus exists in wildlife. The main epidemiologic
cycle is primarily maintained by the red fox (3). It is
reported that canine rabies does not exist in western
European countries; however, the risk is present in
southern and western Europe because of uncontrolled
animals (3).
The incidence of human rabies is very low
throughout the world. On the other hand, it is still
reported in Turkey due to the lack of control of stray
animals (4-6). In the present study, epidemiological
features, transmission route, prophylaxis schedule,
and clinical findings of rabies cases were evaluated,
based on Ministry of Health (MoH) data from 1992 to
2007.
Patients and methods
In Turkey notification of rabies and risky contact is
performed according to the legal regulations set forth
by the Rabies Control and Protection Directive and
the Communicable Diseases Notification System
Directive (7-9). Cases of probable human rabies are
reported within 24 h to the MoH. Details, such as
patient history, complaints, clinical findings, and
prophylaxis, are sent to the MoH via fax or regular
post by the Provincial Health Directorate.
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In the present study, case reports that were sent to
the MoH from the Provincial Health Directorate were
evaluated retrospectively. Patient demographic
features, province of residence, animal contact, time
of rabies risky contact, wound location, presence of a
prophylaxis schedule and its appropriateness, clinical
findings, and duration between exposure and
complaints were recorded. The cases were evaluated
in 2 groups: probable cases and confirmed cases.
The confirmation criteria used for diagnosis of the
rabies cases are described below (10):
• Detection of rabies virus antigens with direct
fluorescent antibody (DFA) in post-mortem
samples (especially brain tissue);
• Identification of rabies virus antigens with DFA
from a corneal smear or nerve tissue samples
taken from hair follicles in the neck;
• Isolation of rabies virus from brain tissue,
saliva, or cerebrospinal fluid (CSF) samples
(animal inoculation or tissue cultures);
• Detection of neutralizing antibodies in ≥1/5
titers in serum or CSF with the rapid
fluorescent focus inhibition test (RFFIT) in
unvaccinated individuals;
• Detection of rabies virus genomic sequences
with polymerase chain reaction (PCR) in postmortem or ante-mortem samples (brain tissue,
skin, cornea, or saliva).
Case classification:
Probable case: A case compatible with the clinical
description and with a medical history of rabies risky
contact;
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Confirmed case: A probable case laboratoryconfirmed by one of the laboratory results.
Rabies risky contact
All domestic and wild animal bites pose a risk for
rabies. Other exposures accepted as posing a risk for
rabies are open wounds, incision or mucous
membrane contact with potentially infectious
material, such as saliva or neural tissues, and
lacerations (7).
Appropriateness of prophylaxis
The Rabies Protection and Control Directive and
WHO’s Updated Rabies Prophylaxis Guide were used
for evaluation of the appropriateness of prophylaxis
(7,11).
Results
There were 39 cases of rabies reported to the MoH
between 1992 and 2007. Diagnosis was confirmed in
17 (43.6%) cases. In the remaining 22 cases, diagnosis
was performed according to epidemiological history
and clinical findings (Table 1). Of the 39 cases, 31
(79.5%) were in males and 8 (20.5%) were in females.
Mean age of the patients was 28.6 ± 19.3 years (range:
5-69 years).
Table 1. Distribution of suspected and confirmed human rabies
cases, according to year.
Year

Confirmed cases

Probable cases

Total

1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2006
2007

2
4
0
1
1
0
1
3
0
1
0
0
2
1
1

3
0
1
0
0
5
2
4
3
2
1
1
0
0
0

5
4
1
1
1
5
3
7
3
3
1
1
2
1
1

Total

17

22

39

August 2009

İstanbul was the province with the most rabies
cases (n = 11), followed by Şanlıurfa (n = 5) and İzmir
(n = 4) (Table 2). The most frequent risky animal
contact was with dogs (29), followed by wild animals
(3) and foxes (2) (Table 3). When the patients were
evaluated regarding post-exposure prophylaxis, 22
were unvaccinated and 17 were vaccinated. Among
the vaccinated patients, 5 were vaccinated 15 days
after exposure and 12 were vaccinated on the
exposure day. Of the 12 patients vaccinated on the
exposure day, 7 were not administered rabies
immunoglobulin. Of the 5 patients that were
administered rabies immunoglobulin, 2 were given
rabies immunoglobulin on the exposure day. In 2 of
the remaining 3 patients, rabies immunoglobulin was
administered on the first and ninth day after the
exposure. In 1 case, a suture was performed before
rabies immunoglobulin and vaccine administration.
Rabies developed in 2 cases despite the fact that
prophylaxis was performed at the appropriate time
and with the proper dose (Table 4).
The time between rabies risky contact and
symptom onset was between 14 days and 1 year for
confirmed cases, versus between 15 days and 3 years
for probable cases. In confirmed cases the duration
between symptom onset and death was 1-13 days,
versus 1-5 days for probable cases.
Diagnosis of rabies was confirmed pathologically
in 16 cases. In 1 case the PCR test was positive. The
site of exposure was the head and the upper
extremities in 28 (71.8%) cases (Table 5). Symptoms
and clinical findings were compatible with the
paralytic form of rabies in 6 cases and the other 33
cases involved the encephalitic form (Table 5).
Discussion
Rabies occurs in all countries, except Antarctica
and some island countries. It is one of the most
frequent causes of viral mortality in developing
countries (12). Unfortunately, Turkey is the only
European country in which street rabies-related
human cases occur because of stray animals. When the
annual distribution of probable and confirmed cases
was evaluated in this study, 1 or 2 cases were observed
annually during the last 5 years (Table 1). Annually,
more than 10 million people, mostly in Asia, receive
593
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Table 2. Distribution of human rabies cases, according to
province.

Table 3. Distribution of human rabies, according to exposure
time and animal contact.

Province

Confirmed cases
(n = 17)

Probable cases
(n = 22)

Exposure time/
Animal contact

İstanbul

5

6

Adana

1

1

İzmir

4

0

Manisa

2

1

Exposure time
January
February
March
April
May
June
July
August
September
October
November
December
Unknown
Animal contact
Dog
Wild animal
Fox
Donkey
Unknown

Gaziantep

0

2

Zonguldak

1

0

Kocaeli

1

0

Şanlıurfa

0

5

Adıyaman

2

0

Siirt

0

3

Kilis

0

1

Şırnak

0

1

Bursa

0

1

Bingöl

0

1

Ağrı

1

0

Confirmed cases
(n = 17)

Probable cases
(n = 22)

2
1
2
1
0
2
3
3
1
0
0
2

3
1
2
1
1
2
1
4
2
1
2
2

12
0
1
1
3

17
3
1
0
1

Table 4. Distribution of human rabies cases, according to type of prophylaxis.
Vaccination

Confirmed cases

Probable cases

10

12

4-dose HDCV*

1

6

3-dose HDCV*

2

0

2-dose HDCV*

1

0

1-dose HDCV*

2

2

15-dose nerve tissue vaccine

0

1

Unvaccinated
Vaccinated

4-dose nerve tissue vaccine

1

0

Unknown

0

1

Rabies immunoglobulin administration

3

3

Appropriateness of rabies immunoglobulin administration

1

1

Appropriateness of post-exposure prophylaxis

1

Duration between rabies risky contact and vaccination (day) 0.** – 60
*Human diploid cell vaccine
**Rabies risky contact day
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Table 5. Exposure site, symptoms, and clinical findings of the human rabies cases.
Exposure site/Symptoms and clinical findings
Exposure site
Head
Upper extremity
Lower extremity
Unknown
Undetected
Symptoms and clinical findings
Hydrophobia, aerophobia
Agitation, confusion
Extremity pain, paresthesia, extremity weakness, paralysis

post-exposure vaccination against the disease,
according to the WHO (2). Nerve tissue vaccines,
which cause neurological side effects, are still used in
some countries. In Turkey, use of nerve tissue vaccine
has decreased since 1986 and only cell culture vaccine
has been used since 1996. Cell culture vaccine is
supplied by the MoH and all post-exposure
prophylaxis is free of charge. According to the present
study’s results, nerve tissue vaccine was used in only 2
patients; all other patients were vaccinated with human
diploid cell vaccine. We think that the decrease in the
number of cases was associated with the use of human
diploid cell vaccine and horse-originated rabies
immunoglobulin distributed by the MoH.
Eleven cases were reported from İstanbul, 5 from
Şanlıurfa, and 4 from İzmir. This could be related to
İstanbul’s uncontrolled stray animals and large
population. An evaluation of the epidemiological
distribution shows that Southeast Anatolia and East
Anatolia were the areas in second place for frequency
of cases.
Worldwide, dogs account for 54% of animal rabies,
terrestrial wildlife accounts for 42%, and bats account
for 4% (12). The epidemiology of human rabies
reflects the epidemiology of animal rabies (13). In
developing areas where canine rabies remains
common, most human cases result from dog bites
(12). In a study by Si et al. in which rabies
epidemiology was investigated it was reported that
87.5% of 244 human rabies cases were caused by dog
bites and 3.7% by cat bites between 1999 and 2007
(14). In a study performed between 1980 and 1996 in

Confirmed cases

Probable cases

5
8
0
3
1

8
7
2
3
0

8
5
3

11
9
3

the USA Noah et al. reported that among 32 cases, 17
(53%) were associated with rabies virus variants found
in insectivorous bats, 12 (38%) with variants found in
domestic dogs outside the United States, 2 (6%) with
variants found in indigenous domestic dogs, and 1
(3%) with a variant found in indigenous skunks (15).
Because all dogs are vaccinated and controlled, most
human cases develop after exposure to wild animals
in developed countries (3).
Rabies is preventable with appropriate wound care
and post-exposure prophylaxis. Rabies prevalence of
the animal, type of animal, and type of exposure (with
provocation or not) are important factors in deciding
if post-exposure prophylaxis is needed. In Turkey
exposure to all stray animals has to be thought of as
rabies risky exposure.
Of the 39 cases in the present study that were
reported to the MoH as confirmed or probable cases,
in 22 (56%) post-exposure prophylaxis could not been
given because the patients did not present to a
healthcare center for prophylaxis. In all, 17 patients
presented for post-exposure prophylaxis, but 5 of them
were late. The other problem that must be stressed is
the low immunoglobulin administration rate. There are
also some problems regarding timely immunoglobulin
administration and appropriate techniques in clinical
practice. Education programs for the general public and
healthcare personnel must be ongoing.
Previous recommendations have called for half of
the dose to be injected around the wound and the
remainder to be injected intramuscularly in the gluteal
region (12). Recently, the WHO and CDC
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recommended that all of the rabies immunoglobulin
should be injected into and around the wound
(11,16,17). Failure to inject rabies immunoglobulin or
surgical closure of the wound prior to immunoglobulin
injection has been associated with the development of
rabies, despite other appropriate post-exposure
prophylaxes (12,18). In the present study the
development of rabies in 2 cases despite prophylaxis
might have been due to improper administration site of
rabies immunoglobulin; however, we were unable to
obtain the details concerning immunoglobulin
injection in and around the wounds.
There is no established specific treatment for
rabies once symptoms have begun (12). Thus postexposure prophylaxis is crucial. Variables affecting the
development of rabies include viral inoculums,
number of bites, and bite localization. The incubation
period for rabies varies from a few days to over 19
years (12). In the present study the incubation period
was between 14 days and 3 years. Initial symptoms
resemble those of other systemic viral infections,
including fever, headache, malaise, and disorders of
the upper respiratory and gastrointestinal tracts
(12,20). Initial neurological symptoms may include
subtle changes in personality and cognition, and
paresthesia or pain near the exposure site. Rabies is

Turk J Med Sci

rarely considered early in the differential diagnosis
(12). The prodrome is reported to occur between 4
and 10 days (20,21).
Human rabies infections are divided into 2 forms:
encephalitic and paralytic. The encephalitic form
presents with hydrophobia, delirium, and agitation.
About a fifth of patients present with the paralytic
form and have little clinical evidence of cerebral
involvement until late in the course of the disease (12).
In the present study 6 cases were clinically compatible
with the paralytic form. Clinical findings indicated
the encephalitic form of rabies in the remaining 33
cases.
Death usually occurs 18 days after the onset of
symptoms (20). In the present study death occurred 113 days after the onset of symptoms. The short
duration between symptom onset and death might
have been related to delayed presentation for postexposure prophylaxis.
In conclusion, the most important problem in
Turkey is the low rate of presentation for postexposure prophylaxis. To solve this problem,
education programs for the general public about the
prophylaxis of rabies must be ongoing.
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